- THE MAGAZINE
“This strategically important acquisition will enable us to enter a number of additional silica sol markets, primarily in Europe,” said Rob Frohn, Akzo Nobel’s board member responsible for Specialty Chemicals. “Our streamlined chemicals portfolio is primed for investment and this transaction emphasizes our commitment to focusing on growth.”
“Akzo Nobel is the ideal partner for our future expansion,” said H.C. Starck Silica Sol’s Managing Directors Gabriele Hey, Ph.D., and Sven Marienfeld. “With the support of Akzo Nobel, we are well positioned continue to pursue our growth strategy.”
For more information, visit www.hcstarck.com or www.akzonobel.com.